141 related articles for article (PubMed ID: 15190302)
1. Antiplatelet agents.
Cattaneo M
Hematol J; 2004; 5 Suppl 3():S170-4. PubMed ID: 15190302
[No Abstract] [Full Text] [Related]
2. Antiplatelet agents.
Varon D; Spectre G
Hematology Am Soc Hematol Educ Program; 2009; ():267-72. PubMed ID: 20008209
[TBL] [Abstract][Full Text] [Related]
3. The role of platelets in peripheral arterial disease: therapeutic implications.
Matsagas MI; Geroulakos G; Mikhailidis DP
Ann Vasc Surg; 2002 Mar; 16(2):246-58. PubMed ID: 11972262
[TBL] [Abstract][Full Text] [Related]
4. Aspirin and clopidogrel resistance: possible mechanisms and clinical relevance. Part I: Concept of resistance.
Vadász D; Sztriha LK; Sas K; Vecsei L
Ideggyogy Sz; 2012 Nov; 65(11-12):377-85. PubMed ID: 23289172
[TBL] [Abstract][Full Text] [Related]
5. Clopidogrel provides significantly greater inhibition of platelet activity than aspirin when combined with atorvastatin after coronary artery bypass grafting: a prospective randomized study.
Tetik S; Ak K; Isbir S; Eksioglu-Demiralp E; Arsan S; Iqbal O; Yardimci T
Clin Appl Thromb Hemost; 2010 Apr; 16(2):189-98. PubMed ID: 19703819
[TBL] [Abstract][Full Text] [Related]
6. Antiplatelet therapy in diabetes: efficacy and limitations of current treatment strategies and future directions.
Angiolillo DJ
Diabetes Care; 2009 Apr; 32(4):531-40. PubMed ID: 19336638
[No Abstract] [Full Text] [Related]
7. Effects of diabetes mellitus on platelet reactivity after dual antiplatelet therapy with aspirin and clopidogrel.
van Werkum JW; Topcu Y; Postma S; Kelder JC; Hackeng CM; ten Berg JM; Verheugt FW
Thromb Haemost; 2008 Mar; 99(3):637-9. PubMed ID: 18327417
[No Abstract] [Full Text] [Related]
8. Proposal of a "gradient model" to evaluate residual platelet activity on antiplatelet therapy: A pilot study.
Lelli N; Rizkallah R; Ferrari P; Pedretti S; Cariani E; Trenti T
Thromb Res; 2017 Feb; 150():19-21. PubMed ID: 27992784
[No Abstract] [Full Text] [Related]
9. Antiplatelet agents and arterial thrombosis.
Billett HH
Cardiol Clin; 2008 May; 26(2):189-201, vi. PubMed ID: 18406994
[TBL] [Abstract][Full Text] [Related]
10. Acute coronary syndrome: are intervention and IIb/IIIa platelet inhibitors epiphenomena?
Jackson G
Int J Clin Pract; 2001; 55(6):351-2. PubMed ID: 11501219
[No Abstract] [Full Text] [Related]
11. [Pharmazie in unserer Zeit 4/2009].
Alban S; Dingermann T
Pharm Unserer Zeit; 2009; 38(4):295. PubMed ID: 19572344
[No Abstract] [Full Text] [Related]
12. The rationale for and comparisons of different antiplatelet treatments in acute coronary syndrome.
Gurbel PA; Tantry US
J Interv Cardiol; 2008 Dec; 21 Suppl 1():S10-7. PubMed ID: 19090932
[TBL] [Abstract][Full Text] [Related]
13. Antithrombotic treatment of NSTEMI/UAP. The interaction with PCI.
Otterstad JE; Brosstad F
Scand Cardiovasc J; 2004 Mar; 38(1):9-15. PubMed ID: 15204241
[No Abstract] [Full Text] [Related]
14. Update on clinical trials of antiplatelet therapy for cerebrovascular diseases.
Bhatt DL; Kapadia SR; Yadav JS; Topol EJ
Cerebrovasc Dis; 2000; 10 Suppl 5():34-40. PubMed ID: 11096181
[TBL] [Abstract][Full Text] [Related]
15. New thoughts on strategies for modulating platelet function through the inhibition of surface receptors.
Nurden AT
Haemostasis; 1996 Oct; 26 Suppl 4():78-88. PubMed ID: 8979114
[TBL] [Abstract][Full Text] [Related]
16. Measuring antiplatelet drug effects in the laboratory.
Harrison P; Frelinger AL; Furman MI; Michelson AD
Thromb Res; 2007; 120(3):323-36. PubMed ID: 17239428
[TBL] [Abstract][Full Text] [Related]
17. Antiplatelet drugs for patients at high cardiovascular risk. Aspirin generally remains the best choice.
Prescrire Int; 2009 Dec; 18(104):272-3. PubMed ID: 20027714
[No Abstract] [Full Text] [Related]
18. Effects of clopidogrel and aspirin combination versus aspirin alone on platelet aggregation and major receptor expression in patients with heart failure: the Plavix Use for Treatment Of Congestive Heart Failure (PLUTO-CHF) trial.
Serebruany VL; Malinin AI; Jerome SD; Lowry DR; Morgan AW; Sane DC; Tanguay JF; Steinhubl SR; O'connor CM
Am Heart J; 2003 Oct; 146(4):713-20. PubMed ID: 14564328
[TBL] [Abstract][Full Text] [Related]
19. Variability of response to antiplatelet therapy: what should we do next?
Shantsila E; Lip GY
Fundam Clin Pharmacol; 2009 Feb; 23(1):19-22. PubMed ID: 19267768
[No Abstract] [Full Text] [Related]
20. Antiplatelet agents for stroke prevention.
Paciaroni M; Gallai V
Cerebrovasc Dis; 2000; 10 Suppl 4():36-9. PubMed ID: 11070399
[No Abstract] [Full Text] [Related]
[Next] [New Search]
